Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

Roche - Basel

Roche taps local expertise for hep C drug in China

Partners with Chinese-American biotech company Ascletis

- PMLiVE

Royalty Pharma sweetens bid for Elan

Says new offer places $4.4bn value on Tysabri royalties

- PMLiVE

AstraZeneca signs cancer biomarkers discovery deal

Partners with UK firm on personalised oncology drug research

Astellas appoints Dr Songlin Xue head of global pharmacovigilance

He joins from Takeda and was formerly at Novartis and Wyeth

- PMLiVE

Healthcare ‘freakonomics’

Understanding the economics of the healthcare market enables us to limit the impact of the system’s inherent failures

Rare disease patients face 5-7 year wait for diagnosis

Doctors often lack time and resources to manage patients

- PMLiVE

Switzerland and pharma forge pricing and access pact

Prices of 2,500 drugs set to fall when price referencing scheme begins

- PMLiVE

Boehringer backs gene therapy firm Eyevensys

Invests in French eye disease specialist

- PMLiVE

Sanofi supports Clexane with Spanish VTE apps

The free iPhone, iPad and Android apps are for healthcare professionals

- PMLiVE

EMA recommends heart risk restriction for Servier’s Protelos

Use of osteoporosis drug likely to be further tightened up

Bupa appoints chief risk officer

Gerry Kelly joins from Lloyds

The evolving landscape of medical education

With new stakeholders, multimedia channels and budget constraints, medical education is changing fast

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links